The Promising Future Of Orthobiologics In Treating Musculoskeletal Injuries
![]() |
| Orthobiologics |
Sports-related injuries are frequent among athletes and anyone who
participate in physical activity. These wounds range in severity from minor
sprains and strains to fractures and ligament tears. Orthobiologics, a potential field of medicine for treating sports
injuries, includes biological elements such stem cells, growth factors, and platelet-rich
plasma.
The
Global
Orthobiologics Market Is Estimated To Be Valued At US$ 6,515.2 Million In 2022 And Is Expected To Exhibit
A CAGR Of 5.9% During The Forecast Period (2022-2030).
Orthobiologics is a rapidly growing field within orthopedics that
involves the use of biological substances to promote healing and regeneration
of musculoskeletal tissues. The field includes a wide range of products and
techniques, including growth factors, stem cells, platelet-rich plasma (PRP),
and other biologic materials. Orthobiologics have the potential to revolutionize the way we treat musculoskeletal
injuries and disorders, and they are increasingly being used in both surgical
and non-surgical settings.
The concept of using biological substances to promote healing is not
new. In fact, physicians have been using various forms of Orthobiologics for centuries. For example, in the late 1800s,
physicians were using autograft bone (bone taken from the patient's own body)
to promote healing of bone fractures. However, it was not until the development
of modern techniques for isolating and purifying biologic substances that the
field of orthobiologics really began to take off.

Comments
Post a Comment